Literature DB >> 34326217

The overlooked superpower of mRNA vaccines.

Meredith Wadman.   

Abstract

Mesh:

Substances:

Year:  2021        PMID: 34326217     DOI: 10.1126/science.373.6554.479

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

Review 1.  mRNA-based modalities for infectious disease management.

Authors:  Mengjie Zhang; Abid Hussain; Haiyin Yang; Jinchao Zhang; Xing-Jie Liang; Yuanyu Huang
Journal:  Nano Res       Date:  2022-07-06       Impact factor: 10.269

2.  Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients Who Were Either Fully Vaccinated with Coronavac or Not: An Analytical, Cross Sectional Study.

Authors:  Serap Şimşek Yavuz; Gülşah Tunçer; Özlem Altuntaş-Aydın; Mehtap Aydın; Filiz Pehlivanoğlu; Yeşim Tok; Sevim Mese; Alper Gündüz; Ceyda Geyiktepe Güçlü; İklima Özdoğan; Börçe Hemiş-Aydın; Pınar Soğuksu; Aysun Benli; Seniha Başaran; Kenan Midilli; Haluk Eraksoy
Journal:  Vaccines (Basel)       Date:  2022-05-07

Review 3.  mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.

Authors:  Yingqi Jin; Chen Hou; Yonghao Li; Kang Zheng; Chuan Wang
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

4.  Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic.

Authors:  Felicita Heidler; Uwe Klaus Zettl; Jörg Richter; Julia Baldt; Niklas Frahm; Silvan Elias Langhorst; Pegah Mashhadiakbar; Barbara Streckenbach; Katja Burian
Journal:  Sci Rep       Date:  2022-09-07       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.